Pfizer scores FDA nod for hemophilia B gene therapy, will charge $3.5M per dose
26th April 2024 Uncategorised 0 Pfizer scores FDA nod for hemophilia B gene therapy, will charge $3.5M per dose
kdunleavy
Fri, 04/26/2024 – 10:21
More: Pfizer scores FDA nod for hemophilia B gene therapy, will charge .5M per dose
Source: fierce